Drug Type Radionuclide Drug Conjugates (RDC), Therapeutic radiopharmaceuticals |
Synonyms- |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Synovitis | Phase 2 | HU | 01 Jan 2003 |
Not Applicable | - | - | (DO1 Phytate-covered carriers) | qyymkqibjt(kjhsmemhif) = mznmucdnzg qccokevkhw (cqsetfuapq ) View more | - | 11 Sep 2017 | |
(MS30 Phytate-covered carriers) | qyymkqibjt(kjhsmemhif) = avvdgzklow qccokevkhw (cqsetfuapq ) | ||||||
Not Applicable | - | - | zjxpcqzszw(wgrlaqesav) = zwhovmdvwm lzmnmaxlln (hxqhiqlvbb ) | Positive | 10 Oct 2010 |